NCT02049489 - A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions

Glioblastoma Multiforme

Interventions

BIOLOGICAL

ICT-121 DC vaccine

autologous dendritic cells pulsed with peptide antigens

Trial Locations (6)

Penn State Hershey Neuroscience Institute, Hershey

University of Alabama at Birmingham, Birmingham

Baylor Research Institute - Charles A. Sammons Cancer Center, Dallas

Cedars-Sinai Medical Center, Los Angeles

UC San Diego Moores Cancer Center, La Jolla

JFK New Jersey Neuroscience Institute, Edison